CANF is currently covered by 2 analysts with an average price target of $7.5. This is a potential upside of $6.06 (420.83%) from yesterday's end of day stock price of $1.44.
Can Fite Biopharma Ltd ADR's activity chart (see below) currently has 30 price targets and 32 ratings on display. The stock rating distribution of CANF is 80% BUY and 20% HOLD.
Analysts' price targets on this stock were met 38.02% of the time, taking 240 days on average.
Highest price target for CANF is $8, Lowest price target is $7, average price target is $7.5.
Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 02-Jul-2026. First documented stock forecast 13-Jun-2018.
Currently out of the existing stock ratings of CANF, 4 are a BUY (80%), 1 are a HOLD (20%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Nov-2025
$8
$6.56 (455.56%)
$5
4 months 20 days ago
(02-Jul-2026)
1/3 (33.33%)
$4.09 (104.60%)
302
Hold Since 13-May-2026
$7
$5.56 (386.11%)
6 months 9 days ago
(13-May-2026)
3/16 (18.75%)
$3.36 (92.31%)
388
Buy Since 24-Sep-2019
$18
$18
2 years 10 days ago
(12-Nov-2024)
5/5 (100%)
$-23.6 (-56.73%)
270
Buy Since 15-Jun-2021
$1650
$1800
4 years 11 months 23 days ago
(30-Nov-2021)
0/2 (0%)
$1410 (587.50%)
What is CANF (Can Fite Biopharma Ltd ADR) average time for price targets to be met?
Which analyst most recently updated their price target on CANF (Can Fite Biopharma Ltd ADR)?
Which analyst has the lowest performance score on CANF (Can Fite Biopharma Ltd ADR) with a proven track record?
Which analyst has the most public recommendations on CANF (Can Fite Biopharma Ltd ADR)?
Which analyst is the currently most bullish on CANF (Can Fite Biopharma Ltd ADR)?
Which analyst is the currently most reserved on CANF (Can Fite Biopharma Ltd ADR)?